A company still losing money with shrinking sales, with high risk.
Facts from SEC filings, not a recommendation.
Last 12 months: $10.6M, up 20% from the 12 months before.
Price chart by TradingView.
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+, share count not growing. A checklist is a starting point for research, not a verdict.
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions held almost none of it the quarter before (new listing, spin-off or ticker change), so there's no fair percent change yet. 20 bought, 1 sold.
| Insider | Trade | Shares | Avg price | Value | Owns after | Date |
|---|---|---|---|---|---|---|
Joseph P. DavyChief Executive Officer | Buy | 116K | $0.00 | $0 | 150K | Sep 28Filing ↗ |
| ||||||
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
115,965 shares
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page